263 related articles for article (PubMed ID: 31196067)
1. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
Bank PCD; Swen JJ; Guchelaar HJ
BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
[TBL] [Abstract][Full Text] [Related]
2. Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK.
Youssef E; Kirkdale CL; Wright DJ; Guchelaar HJ; Thornley T
Br J Clin Pharmacol; 2021 Jul; 87(7):2907-2925. PubMed ID: 33464647
[TBL] [Abstract][Full Text] [Related]
3. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
4. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
5. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
8. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
9. [Pharmacogenetics in daily practice].
van Gelder T; van Schaik RHN
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
11. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
Hayward J; McDermott J; Qureshi N; Newman W
Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
15. Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services.
Pasternak AL; Ward K; Irwin M; Okerberg C; Hayes D; Fritsche L; Zoellner S; Virzi J; Choe HM; Ellingrod V
Clin Transl Sci; 2023 Feb; 16(2):292-304. PubMed ID: 36510710
[TBL] [Abstract][Full Text] [Related]
16. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
[TBL] [Abstract][Full Text] [Related]
17. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
[TBL] [Abstract][Full Text] [Related]
18. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Weitzel KW; Cavallari LH; Lesko LJ
Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
20. Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
Hicks JK; El Rouby N; Ong HH; Schildcrout JS; Ramsey LB; Shi Y; Anne Tang L; Aquilante CL; Beitelshees AL; Blake KV; Cimino JJ; Davis BH; Empey PE; Kao DP; Lemkin DL; Limdi NA; P Lipori G; Rosenman MB; Skaar TC; Teal E; Tuteja S; Wiley LK; Williams H; Winterstein AG; Van Driest SL; Cavallari LH; Peterson JF;
Clin Pharmacol Ther; 2021 Jul; 110(1):179-188. PubMed ID: 33428770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
